Related Experiment Video
Updated: Dec 29, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Characterization of drug-resistant tuberculosis in Brazil, 2014
Marina Gasino Jacobs1, Vitor Laerte Pinto Junior2
1Universidade de Brasília, Faculdade de Ciências da Saúde, Brasília, DF, Brasil.
Drug-resistant tuberculosis (DR-TB) disproportionately affects young, Afro-Brazilian men with low education. High rates of primary and multidrug-resistance, alongside comorbidities like substance use, highlight significant public health challenges in Brazil.
Area of Science:
- Public Health
- Infectious Diseases
- Epidemiology
Background:
- Tuberculosis remains a global health concern, with drug-resistant strains posing a significant challenge.
- Understanding the epidemiological profile of drug-resistant tuberculosis (DR-TB) is crucial for effective control strategies.
Purpose of the Study:
- To describe the clinical and epidemiological characteristics of DR-TB notifications in Brazil in 2014.
- To identify key demographic and comorbidity factors associated with DR-TB.
Main Methods:
- A descriptive study analyzing data from the SITETB and TBWeb information systems.
- Inclusion of 1,574 DR-TB cases registered in 2014 for analysis.
Main Results:
- Pulmonary form accounted for 94.8% of cases.
- Primary resistance was observed in 27.6%, and multidrug-resistance in 50.9%.
- Affected population: 70.6% male, 87.0% aged 20-59, 60.9% Afro-Brazilian, 68.0% with <8 years of schooling. High prevalence of comorbidities including AIDS (13.1%), diabetes (11.3%), and substance use (alcohol 25.8%, illicit drugs 21.0%, tobacco 22.2%).
Conclusions:
- DR-TB notifications in Brazil predominantly involved young, Afro-Brazilian men with limited education.
- High rates of primary and multidrug-resistance, coupled with prevalent comorbidities, particularly substance use, underscore the complexity of DR-TB management.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Development of Antibiotic Resistance

